News

Under the terms of the agreement, ChemDiv will discover small molecule ligands for biotargets nominated by Syndexa. Financial terms of the collaboration were not disclosed. Teo Uysal, president

This line extension further extends the brand franchise of Lupin’s flagship anti-infective brand Suprax (Cefixime for oral suspension 100mg/5ml and 200mg/5ml). Suprax 400mg tablets will be promoted by

Study results showed that across all dose groups in the study population, the 6.6 mean letter gain in visual acuity achieved versus baseline at the week 16 evaluation

Advance is a comprehensive platform for the performance of traditional nerve conduction studies and invasive electromyography procedures. The device is intended to be used by physicians to perform

Treximet is said to be the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, and an anti-inflammatory pain reliever in

Elixir’s rights to this patent were made possible through an exclusive license. Sirtuins are a class of enzymes believed to play a significant role in diseases of aging,

Teva’s approval is for the 0.5mg base/vial and 1.5mg base/vial strengths as well as the sterile diluent. This product is indicated for the long term intravenous treatment of

Imagify is an ultrasound imaging agent for the detection of coronary artery disease. The new drug application (NDA) includes data from studies of Imagify in more than 1,000

In the FDA’s letter, the agency rejected the proposed trade name Cordaptive for MK-0524A (ER niacin/laropiprant). The company said at the appropriate time it expects to pursue the